about
HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microgliaHuman polyomavirus reactivation: disease pathogenesis and treatment approachesPACAP27 is protective against tat-induced neurotoxicityMolecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainInteraction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseThe cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disordersDiallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaineHIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbiditiesRole of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersTargeting the Brain Reservoirs: Toward an HIV CureHIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidaseHuman immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.HIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure.Menin mediates Tat-induced neuronal apoptosis in brain frontal cortex of SIV-infected macaques and in Tat-treated cells.Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease.Repeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels.STAT3 and its phosphorylation are involved in HIV-1 Tat-induced transactivation of glial fibrillary acidic proteinSynaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.HIV-1-Tat excites cardiac parasympathetic neurons of nucleus ambiguus and triggers prolonged bradycardia in conscious rats.Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transportHIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children.Soy isoflavones genistein and daidzein exert anti-apoptotic actions via a selective ER-mediated mechanism in neurons following HIV-1 Tat(1-86) exposureMutation of tyrosine 470 of human dopamine transporter is critical for HIV-1 Tat-induced inhibition of dopamine transport and transporter conformational transitions.Neuroprotective activity of pDING in response to HIV-1 Tat.Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanismMonocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disordersHIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner.Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression.Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic miceHIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesisOpiate drug use and the pathophysiology of neuroAIDS.Human immunodeficiency virus type 1 (HIV-1) transactivator of transcription through its intact core and cysteine-rich domains inhibits Wnt/β-catenin signaling in astrocytes: relevance to HIV neuropathogenesisEnduring cortical alterations after a single in-vivo treatment of HIV-1 Tat.Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat.Subtype associations with HIV-associated neurocognitive disorder in China
P2860
Q21245231-D6D7F1E6-4E5F-411B-ACC3-37912A4C28ADQ21285083-5B5508D8-33E8-4AD4-B06A-4F6C01D77E71Q24293525-B6F39379-455D-4EFE-8CE6-AF43166A0EB1Q24619923-CD14D81F-8640-4B78-9270-94F6EFFF149CQ26770397-4D77972A-8AE9-4BE8-A676-4E2317E149A0Q26777952-A4A04195-B0DB-4F61-97C4-4980BED6CB17Q26799149-30DF25AA-DD23-4763-BB48-E528595C11E9Q27013928-0D00328A-46FD-4E84-96FC-478C3D60986EQ27015965-B0572376-F310-4110-98C1-E4D118F9E552Q27025573-8674C72B-2788-4312-A30F-76AE97006A73Q28075694-31CE638D-245F-40BD-B43B-87C63DB4F846Q28261913-1AEE91F1-2DBD-4DCC-8838-104E3C24D9E6Q30497248-2C641F34-9F1B-44B5-83E4-81A7D431C3ECQ30638542-95E3D5D7-27CE-4BD6-A8FC-425B1F4A9A48Q33566813-417F4EF9-04BC-4904-BE1D-FB4FD2CB83FFQ33603457-7FCCD732-0221-44ED-A9F8-D56E8618DEB1Q33605370-FE50FFBD-1949-471B-8445-886BFB0EDEC2Q33675464-CA94C702-0296-4CB5-B401-DE0A735CFB9BQ33700996-D6CD5EC8-0312-4EA3-AEE2-204A1039D3EDQ33701989-BA8B6A46-2102-46BD-85D8-C098E7D8E5A6Q33808035-A4B26D83-565E-4EBD-8D37-DC92DCD262A7Q33870898-CCDF0504-0003-4D40-9643-451A382F204CQ33893123-AD7737FC-7D0F-44F6-9AF8-1986A321E919Q34281974-89AB6472-39D6-41AF-A56F-AC2AF3AF35A2Q34343025-FBE8CDE5-F1D2-46B0-9B9C-6969591A9536Q34377554-0954008B-E34F-44AB-868B-759FFABEF96DQ34458860-30E78A1A-58E6-4DD2-819C-85469006DE4CQ35007339-A7EEE80C-F61B-4B1E-8999-56FFFB0A36F6Q35007551-5E1CFBF6-6FB7-4E49-98B3-3BB0724E2935Q35154529-58910FCD-4BA7-41C0-932E-446551E79956Q35183177-E898F0C2-A760-4AD4-8904-B67DF3A542B0Q35317241-6BB4DED8-22E7-4903-8185-73558A008AB2Q35559749-D9B12440-85E4-436E-922A-BF8B2A6DEBC6Q35562611-38B5CA13-A246-4E45-9F0E-1E6FCC878507Q35921136-BE37127C-2D2B-4F3D-8D5B-92BDD4F5FE4AQ36201412-4953C98B-1BA9-4B53-B3CF-E7EBF835AD16Q36430096-C0720DA3-50F2-489C-8BF3-7E8B336DB826Q36562431-49B8960E-1A9E-4D25-BF23-AE420F7065A1Q36609063-B7D01E9F-D385-4462-A27D-DCAE7FC6D04AQ36624481-38ED0217-B2AE-4769-AEF7-E55BA4DE4667
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of Tat protein in HIV neuropathogenesis.
@en
Role of Tat protein in HIV neuropathogenesis.
@nl
type
label
Role of Tat protein in HIV neuropathogenesis.
@en
Role of Tat protein in HIV neuropathogenesis.
@nl
prefLabel
Role of Tat protein in HIV neuropathogenesis.
@en
Role of Tat protein in HIV neuropathogenesis.
@nl
P2093
P2860
P1476
Role of Tat protein in HIV neuropathogenesis.
@en
P2093
Avindra Nath
Guanhan Li
Joseph Steiner
P2860
P2888
P304
P356
10.1007/S12640-009-9047-8
P577
2009-03-21T00:00:00Z